Minnesota cannabis firm expands to research psychedelic medicines
June 10, 2021
Vireo Health International, a producer of cannabis products based in Minneapolis, renamed itself Goodness Growth Holdings and said Wednesday it will begin research in psychedelic medicine.
Executives also gave an upbeat outlook for the company's growth. Its shares, which are traded on the Toronto Stock Exchange and over the counter in the U.S., rose 1.7%.
The company - led by Dr. Kyle Kingsley, a former Twin Cities emergency room doctor disillusioned that much of his work involved abuse of prescription drugs and alcohol - is one of America's leading growers and retailers of cannabis products for medical and recreational purposes.